Timolol

噻吗洛尔

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameTimolol
Drug Alias NameBloaren噻吗心安ModucrenBetimol
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsSurgical WoundWounds and InjuriesSurgical Wound Dehiscence +[14] 
Global Approved IndicationsHypertensionGlaucoma, Open-AngleGlaucoma +[4] 
Approved Indications in ChinaGlaucoma, Open-AngleOcular Hypertension
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryUnited StatesVietnamThailand +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAkornOak Pharmaceuticals, Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Brigham and Women's HospitalThea Pharma IncLaboratoires Thea SAS +[9] 
Inactive CompaniesUniversity Of Medicine And Dentistry Of New JerseyWashington University School Of MedicineJohns Hopkins University +[4] 
Active IndicationsSurgical WoundSurgical Wound DehiscenceErythema +[9] 
Inactive IndicationsWounds and InjuriesRosaceaTelangiectasia, Hereditary Hemorrhagic +[5] 

Other Information

ATC CodeC07AA06S01ED01
Related LinksWikipediaDrugBankKEGG